CN103689744B - 一种高丽红参龙眼饮料的制备工艺 - Google Patents
一种高丽红参龙眼饮料的制备工艺 Download PDFInfo
- Publication number
- CN103689744B CN103689744B CN201410005947.1A CN201410005947A CN103689744B CN 103689744 B CN103689744 B CN 103689744B CN 201410005947 A CN201410005947 A CN 201410005947A CN 103689744 B CN103689744 B CN 103689744B
- Authority
- CN
- China
- Prior art keywords
- longan
- ginseng
- korean
- red ginseng
- filtrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000000235 Euphoria longan Nutrition 0.000 title claims abstract description 30
- 235000013361 beverage Nutrition 0.000 title claims abstract description 11
- 238000004519 manufacturing process Methods 0.000 title abstract description 3
- 244000139609 Euphoria longan Species 0.000 title 1
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 30
- 239000000706 filtrate Substances 0.000 claims abstract description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 18
- 210000000582 semen Anatomy 0.000 claims abstract description 16
- 238000003756 stirring Methods 0.000 claims abstract description 14
- 239000000843 powder Substances 0.000 claims abstract description 13
- 241000186000 Bifidobacterium Species 0.000 claims abstract description 11
- 150000003839 salts Chemical class 0.000 claims abstract description 9
- 230000001954 sterilising effect Effects 0.000 claims abstract description 5
- 235000002789 Panax ginseng Nutrition 0.000 claims description 47
- 235000002791 Panax Nutrition 0.000 claims description 18
- 241000208343 Panax Species 0.000 claims description 18
- 238000000638 solvent extraction Methods 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 13
- 238000005516 engineering process Methods 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 241000186660 Lactobacillus Species 0.000 claims description 7
- 229940039696 lactobacillus Drugs 0.000 claims description 7
- 238000000855 fermentation Methods 0.000 claims description 4
- 230000004151 fermentation Effects 0.000 claims description 4
- 235000008434 ginseng Nutrition 0.000 abstract description 10
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 abstract description 5
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract description 5
- 238000000034 method Methods 0.000 abstract description 4
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract description 3
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 abstract description 3
- 230000006870 function Effects 0.000 abstract description 3
- 230000008569 process Effects 0.000 abstract description 3
- 239000000047 product Substances 0.000 abstract description 3
- 238000012827 research and development Methods 0.000 abstract description 2
- 238000010025 steaming Methods 0.000 abstract description 2
- 238000002386 leaching Methods 0.000 abstract 3
- 240000000038 Ziziphus mauritiana Species 0.000 abstract 2
- 229920000858 Cyclodextrin Polymers 0.000 abstract 1
- 239000001116 FEMA 4028 Substances 0.000 abstract 1
- 241000186612 Lactobacillus sakei Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 abstract 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 abstract 1
- 229960004853 betadex Drugs 0.000 abstract 1
- 238000009924 canning Methods 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 16
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 11
- 240000004371 Panax ginseng Species 0.000 description 9
- 230000001093 anti-cancer Effects 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 239000004310 lactic acid Substances 0.000 description 5
- 235000014655 lactic acid Nutrition 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 4
- 239000000470 constituent Substances 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 244000126002 Ziziphus vulgaris Species 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 235000012907 honey Nutrition 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000726221 Gemma Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 229930192392 Mitomycin Natural products 0.000 description 2
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000007969 cellular immunity Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229960004857 mitomycin Drugs 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 208000007848 Alcoholism Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 208000009849 Female Genital Neoplasms Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- UFNDONGOJKNAES-UHFFFAOYSA-N Ginsenoside Rb1 Natural products CC(=CCCC(C)(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CC(O)C45C)C UFNDONGOJKNAES-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 244000202052 Poncirus trifoliata Species 0.000 description 1
- 235000000404 Poncirus trifoliata Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000219100 Rhamnaceae Species 0.000 description 1
- 241000282849 Ruminantia Species 0.000 description 1
- 208000002495 Uterine Neoplasms Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- OLOZVPHKXALCRI-UHFFFAOYSA-L calcium malate Chemical compound [Ca+2].[O-]C(=O)C(O)CC([O-])=O OLOZVPHKXALCRI-UHFFFAOYSA-L 0.000 description 1
- 239000001362 calcium malate Substances 0.000 description 1
- 229940016114 calcium malate Drugs 0.000 description 1
- 235000011038 calcium malates Nutrition 0.000 description 1
- -1 carrotene Proteins 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- GZYPWOGIYAIIPV-JBDTYSNRSA-N ginsenoside Rb1 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GZYPWOGIYAIIPV-JBDTYSNRSA-N 0.000 description 1
- TXEWRVNOAJOINC-UHFFFAOYSA-N ginsenoside Rb2 Natural products CC(=CCCC(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C TXEWRVNOAJOINC-UHFFFAOYSA-N 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000007688 immunotoxicity Effects 0.000 description 1
- 231100000386 immunotoxicity Toxicity 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 108010004621 phosphoketolase Proteins 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000035946 sexual desire Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 206010046766 uterine cancer Diseases 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/70—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
- A23L2/72—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter by filtration
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/70—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
- A23L2/84—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter using microorganisms or biological material, e.g. enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/179—Sakei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明所属保健食品研究开发技术领域。本发明涉及一种高丽红参龙眼饮料的制备工艺。将浸提罐中装入高丽红参5年根粉末、龙眼、枳椇子、大枣；将β-环糊精溶于80℃蒸参水中，将此溶液注入浸提罐中与高丽红参5年根粉末、龙眼、枳椇子和大枣混合，搅拌和浸提，过滤，得到滤液，重复提取残渣二次；将滤液合并，加入清酒乳杆菌、双歧杆菌，发酵，加红糖、食盐，搅拌，过滤，得到滤液，将滤液装罐或装瓶，灭菌即可。本发明产品具有强身健体的功能。
Description
技术领域
本发明所属保健食品研究开发技术领域。本发明涉及一种高丽红参龙眼饮料的制备工艺。本发明产品具有强身健体的功能。
背景技术
1高丽红参系由产自韩国的高丽鲜参经蒸、烘烤加工而成，在加工高丽红参过程中，有新的抗癌活性成分产生。高丽红参不凉也不热，属于温性；高丽参虽性温但补性强，益气助火。高丽参又分白参和红参，脾虚火旺者宜用白参，因“生用气凉，微苦补阴”;脾虚肺怯者宜用红参，“熟用气温，味甘补阳”。总体来说，高丽参更适合老年气虚症状明显的人服用，能强壮体质，增强免疫力。
高丽红参的功效：
（1）益智健脑：对记忆力减退和运动协调能力下降的人以及经常喝酒或接触带乙醇成分的食物、药物的人，高丽红参具有提高脑力工作能力、增强记忆力和改善脑缺血性障碍的功效
（2）镇痛：一些专家通过做传感神经细胞试验发现，高丽参对身体各种疼痛症状都有所帮助。
（3）防癌和抗癌：高丽红参的皂苷成分和非皂苷成分有抑制多种癌细胞的增殖活性，同时也可抑制癌细胞转移。另外，高丽红参与抗癌剂同服用，抗癌效果要好于单独用抗癌剂(丝裂霉素)。这是因为肿瘤化疗中癌细胞易形成耐受，高丽红参与抗癌剂同服用，增强对癌细胞的杀伤力、减轻抗癌剂的副作用。
（4）增强免疫力：高丽红参提取物可恢复因服用具有免疫毒性的抗癌剂(丝裂霉素)而下降的细胞性免疫反应，尤其乙醚提取物可激活或增强细胞性免疫，及自然杀伤细胞的活性，对提高免疫力有很大的功效。
（5）控制糖尿病：高丽红参含有促进胰岛素分泌和类似胰岛素作用的物质，其中人参皂苷能改善高血糖，有效地控制糖尿病的发生。
（6）健肝：高丽参成分中有抗肝炎活性，具有解毒、保护肝脏及促进肝再生、恢复的作用。此外，高丽红参还有解酒、消除宿醉的作用。
（7）调节血压：高丽红参具有扩张血管作用，能改善血液循环，其中的皂苷成分通过促进血管内皮细胞释放一氧化氮，可达到降血压作用。
（8）抗疲劳及抗压：经研究发现，持续服用高丽红参可以提高运动能力和缓解疲劳，对促进运动员疲劳累积的恢复和预防运动性贫血有很大帮助;此外，高丽红参还可以增强对低温(5℃、O℃、-10℃)及高温(35℃)等不利环境的耐受力，通过对压力或环境变化进行精妙调节，提高抗压能力，维持机体稳定性。
（9）改善女性更年期障碍：据调查，有更年期障碍症状的女性在服用高丽红参后，有80%的人承认服用高丽红参后症状明显改善。专家称，这些女性如根据症状来调整用量，还可提高疗效。
（10）改善男性性功能障碍：高丽红参可防止因压力导致的男性性功能障碍。经临床试验，勃起障碍患者(90人)服用高丽红参后，在勃起程度、性欲及满意度等方面都有所改善。
（11）抗氧化及抗衰老：高丽红参具有抑制有害活性氧的增多和脂类过氧化的抗氧化效果。
2龙眼龙眼又称桂圆，含有多种营养物质，有补血安神，健脑益智，补养心脾的功效。龙眼营养丰富，是珍贵的滋养强化剂。对子宫癌细胞的抑制率超过90%，妇女更年期是妇科肿瘤好发的阶段，适当吃些龙眼有利健康。对病后需要调养及体质虚弱的人有辅助疗效。此外龙眼的叶、花、根、核均可入药。龙眼花是一种重要的蜜源植物，龙眼蜜是蜂蜜中的上等蜜。
3枳椇子枳椇子为鼠李科植物枳椇的带有肉质果柄的果实或种子，含多量葡萄糖、苹果酸钙。解酒毒；止渴除烦；止呕；利大小便。主醉酒；烦渴；呕吐；二便不利。
4大枣大枣又名红枣、干枣、枣子，起源于中国，在中国已有八千多年的种植历史，自古以来就被列为“五果”（栗、桃、李、杏、枣）之一。大枣富含蛋白质、脂肪、糖类、胡萝卜素、B族维生素、维生素C、维生素P以及钙、磷、铁和环磷酸腺苷等营养成分。其中维生素C的含量在果品中名列前茅，有维生素王之美称。
5蒸参水蒸参水是加工红参过程中的副产品，含有单体人参皂苷Rb1、Rb2、Rc、Rd、Re、Rf、Rg等，还含有人参多糖和微量挥发油等。
6乳酸菌（Lactobacillus）是发酵糖类且主要产物为乳酸的一类无芽孢、革兰氏染色阳性细菌的总称。凡是能从葡萄糖或乳糖的发酵过程中产生乳酸的细菌统称为乳酸菌。是一种存在于人类体内的益生菌。乳酸菌可用于制造酸奶、乳酪、啤酒、葡萄酒、泡菜、腌渍食品和其他发酵食品。
7双歧杆菌双歧杆菌Bifidobacterium是1899年由法国学者Tissier从母乳营养儿的粪便中分离出的一种厌氧的革兰氏阳性杆菌，末端常常分叉，故名双歧杆菌。双歧杆菌属革兰氏阳性、厌氧、不运动、无芽孢、形态多变的杆菌,其染色不规则,过氧化氢酶呈阴性。菌落光滑,凸圆边缘完整,乳脂呈白色,闪光并有柔软质地。葡萄糖代谢属异型发酵,具有磷酸转酮酶活性,可将2mol葡萄糖酵解为3mol乙酸和2mol乳酸。广泛存在于人和动物的肠道,反刍动物的瘤胃,以及人的齿缝中。其最适生存温度为37～42℃,最适pH值6.5～7.0。
双歧杆菌具有以下治疗效果：（1）维护肠道正常细菌菌群平衡，抑制病原菌的生长，防止便秘，下痢和胃肠障碍等；（2）抗肿瘤；（3）在肠道内合成维生素、氨基酸和提高机体对钙离子的吸收；（4）降低血液中胆固醇水平，防治高血压；（5）改善乳制品的耐乳糖性，提高消化率；（6）增强人体免疫机能，预防抗生素的副作用，抗衰老，延年益寿。
一参三果制备的高丽红参龙眼饮料具有强身健体的功能。
发明内容
1、一种高丽红参龙眼饮料的制备工艺，特征在于其步骤如下：
（1）原辅料组成及配比为高丽红参5年根粉末0.1-1.5kg、龙眼0.2-3.0kg、枳椇子0.2-3.0kg、大枣0.1-2.0kg、β-环糊精0.015-0.300kg、蒸参水0.6-12.0L、0.1-0.2%清酒乳杆菌、0.1-0.2%双歧杆菌、红糖0.05-1.00kg、食盐0.001-0.006kg；
（2）将浸提罐中装入高丽红参5年根粉末0.1-1.5kg、龙眼0.2-3.0kg、枳椇子0.2-3.0kg、大枣0.1-2.0kg；
（3）将β-环糊精0.005-0.100kg溶于80℃蒸参水0.2-4.0L中，将此溶液注入浸提罐中与高丽红参5年根粉末0.1-1.5kg、龙眼0.2-3.0kg、枳椇子0.2-3.0kg、大枣0.1-2.0kg混合，搅拌和浸提3-4h，过滤，得到滤液和残渣；
（4）取β-环糊精0.005-0.100kg溶于80℃蒸参水0.2-4.0L中，将此溶液注入浸提罐中与（3）中残渣混合，搅拌和浸提2-3h，过滤，得到滤液和残渣；
（5）取β-环糊精0.005-0.100kg溶于80℃蒸参水0.2-4.0L中，将此溶液注入浸提罐中与（4）中残渣混合，搅拌和浸提1-2h，过滤，得到滤液和残渣；
（6）将（3）、（4）和（5）中滤液合并，加入0.1-0.2%清酒乳杆菌和0.1-0.2%双歧杆菌，在37-42℃发酵24-36h；
（7）将（6）中溶液加红糖0.05-1.00kg、食盐0.001-0.006kg，搅拌，过滤，得到滤液，将滤液装罐或装瓶，120-125℃，10-15分钟灭菌即可。
具体实施方式
本发明所述的涉及一种高丽红参龙眼饮料的制备工艺包括以下实施例，下面的实施例可进一步说明本发明，但不以任何方式限制本发明。
实施例1:
1、一种高丽红参龙眼饮料的制备工艺，特征在于其步骤如下：
（1）原辅料组成及配比为高丽红参5年根粉末0.1kg、龙眼0.2-3.0kg、枳椇子0.2-3.0kg、大枣0.1kg、β-环糊精0.015kg、蒸参水0.6L、红糖0.05kg、食盐0.001kg；
（2）将浸提罐中装入高丽红参5年根粉末0.1kg、龙眼0.2kg、枳椇子0.2kg、大枣0.1kg；
（3）将β-环糊精0.005kg溶于80℃蒸参水0.2L中，将此溶液注入浸提罐中与高丽红参5年根粉末0.1kg、龙眼0.2kg、枳椇子0.2kg、大枣0.1kg混合，搅拌和浸提3h，过滤，得到滤液和残渣；
（4）取β-环糊精0.005kg溶于80℃蒸参水0.2L中，将此溶液注入浸提罐中与（3）中残渣混合，搅拌和浸提2h，过滤，得到滤液和残渣；
（5）取β-环糊精0.005kg溶于80℃蒸参水0.2L中，将此溶液注入浸提罐中与（4）中残渣混合，搅拌和浸提1h，过滤，得到滤液和残渣；
（6）将（3）、（4）和（5）中滤液合并，加入0.1%清酒乳杆菌和0.1%双歧杆菌，在37℃发酵36h；
（7）将（6）中溶液加红糖0.05kg、食盐0.001kg，搅拌，过滤，得到滤液，将滤液装罐或装瓶，120℃，15分钟灭菌即可。
实施例2:
1、一种高丽红参龙眼饮料的制备工艺，特征在于其步骤如下：
（1）原辅料组成及配比为高丽红参5年根粉末1.5kg、龙眼3.0kg、枳椇子3.0kg、大枣2.0kg、β-环糊精0.300kg、蒸参水12.0L、红糖1.00kg、食盐0.006kg；
（2）将浸提罐中装入高丽红参5年根粉末1.5kg、龙眼3.0kg、枳椇子3.0kg、大枣2.0kg；
（3）将β-环糊精0.100kg溶于80℃蒸参水4.0L中，将此溶液注入浸提罐中与高丽红参5年根粉末1.5kg、龙眼3.0kg、枳椇子3.0kg、大枣2.0kg混合，搅拌和浸提4h，过滤，得到滤液和残渣；
（4）取β-环糊精0.100kg溶于80℃蒸参水4.0L中，将此溶液注入浸提罐中与（3）中残渣混合，搅拌和浸提3h，过滤，得到滤液和残渣；
（5）取β-环糊精0.100kg溶于80℃蒸参水4.0L中，将此溶液注入浸提罐中与（4）中残渣混合，搅拌和浸提2h，过滤，得到滤液和残渣；
（6）将（3）、（4）和（5）中滤液合并，加入0.2%清酒乳杆菌和0.2%双歧杆菌，在42℃发酵24h；
（7）将（6）中溶液加红糖1.00kg、食盐0.006kg，搅拌，过滤，得到滤液，将滤液装罐或装瓶，125℃，10分钟灭菌即可。
Claims (1)
1.一种高丽红参龙眼饮料的制备工艺，特征在于其步骤如下：
（1）原辅料组成及配比为高丽红参5年根粉末0.1-1.5kg、龙眼0.2-3.0kg、枳椇子0.2-3.0kg、大枣0.1-2.0kg、β-环糊精0.015-0.300kg、蒸参水0.6-12.0L、0.1-0.2%清酒乳杆菌、0.1-0.2%双歧杆菌、红糖0.05-1.00kg、食盐0.001-0.006kg；
（2）将浸提罐中装入高丽红参5年根粉末0.1-1.5kg、龙眼0.2-3.0kg、枳椇子0.2-3.0kg、大枣0.1-2.0kg；
（3）将β-环糊精0.005-0.100kg溶于80℃蒸参水0.2-4.0L中，将此溶液注入浸提罐中与高丽红参5年根粉末0.1-1.5kg、龙眼0.2-3.0kg、枳椇子0.2-3.0kg、大枣0.1-2.0kg混合，搅拌和浸提3-4h，过滤，得到滤液和残渣；
（4）取β-环糊精0.005-0.100kg溶于80℃蒸参水0.2-4.0L中，将此溶液注入浸提罐中与（3）中残渣混合，搅拌和浸提2-3h，过滤，得到滤液和残渣；
（5）取β-环糊精0.005-0.100kg溶于80℃蒸参水0.2-4.0L中，将此溶液注入浸提罐中与（4）中残渣混合，搅拌和浸提1-2h，过滤，得到滤液和残渣；
（6）将（3）、（4）和（5）中滤液合并，加入0.1-0.2%清酒乳杆菌和0.1-0.2%双歧杆菌，在37-42℃发酵24-36h；
（7）将（6）中溶液加红糖0.05-1.00kg、食盐0.001-0.006kg，搅拌，过滤，得到滤液，将滤液装罐或装瓶，120-125℃，10-15分钟灭菌即可。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410005947.1A CN103689744B (zh) | 2014-01-07 | 2014-01-07 | 一种高丽红参龙眼饮料的制备工艺 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410005947.1A CN103689744B (zh) | 2014-01-07 | 2014-01-07 | 一种高丽红参龙眼饮料的制备工艺 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103689744A CN103689744A (zh) | 2014-04-02 |
| CN103689744B true CN103689744B (zh) | 2014-12-03 |
Family
ID=50351532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410005947.1A Active CN103689744B (zh) | 2014-01-07 | 2014-01-07 | 一种高丽红参龙眼饮料的制备工艺 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103689744B (zh) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101214363A (zh) * | 2007-12-29 | 2008-07-09 | 顾伟民 | 一种解酒饮液及其制备方法 |
| CN102286348A (zh) * | 2011-09-10 | 2011-12-21 | 遵义市天星中草医药研究所 | 一种养生酒 |
| CN102293435A (zh) * | 2011-08-17 | 2011-12-28 | 季时付 | 植物保健饮品及其制备方法 |
| CN102389144A (zh) * | 2011-11-14 | 2012-03-28 | 厦门亦坤果蔬专业合作社 | 一种龙眼饮料及其制作工艺 |
| CN102511597A (zh) * | 2011-12-30 | 2012-06-27 | 苏州爱斯欧蒂生物科技有限公司 | 保健饮品 |
| CN103127202A (zh) * | 2011-11-30 | 2013-06-05 | 韩国食品硏究院 | 利用红参的红景天发酵物的制造方法及含有该发酵物的改善疲劳和提高运动能力的组合物 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101346627B1 (ko) * | 2011-02-08 | 2014-01-07 | 김재광 | 유산균 및 효소의 복합 발효를 이용한 홍삼액의 제조방법 |
-
2014
- 2014-01-07 CN CN201410005947.1A patent/CN103689744B/zh active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101214363A (zh) * | 2007-12-29 | 2008-07-09 | 顾伟民 | 一种解酒饮液及其制备方法 |
| CN102293435A (zh) * | 2011-08-17 | 2011-12-28 | 季时付 | 植物保健饮品及其制备方法 |
| CN102286348A (zh) * | 2011-09-10 | 2011-12-21 | 遵义市天星中草医药研究所 | 一种养生酒 |
| CN102389144A (zh) * | 2011-11-14 | 2012-03-28 | 厦门亦坤果蔬专业合作社 | 一种龙眼饮料及其制作工艺 |
| CN103127202A (zh) * | 2011-11-30 | 2013-06-05 | 韩国食品硏究院 | 利用红参的红景天发酵物的制造方法及含有该发酵物的改善疲劳和提高运动能力的组合物 |
| CN102511597A (zh) * | 2011-12-30 | 2012-06-27 | 苏州爱斯欧蒂生物科技有限公司 | 保健饮品 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103689744A (zh) | 2014-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102805170B (zh) | 一种红茶菌饮料及其制备工艺及其应用 | |
| CN103519283A (zh) | 一种猕猴桃发酵饮料及制备方法和应用 | |
| CN101919553A (zh) | 刺梨果味饮料 | |
| CN104305427A (zh) | 葡萄红茶菌饮料 | |
| CN103504444A (zh) | 一种灵芝竹荪固体饮料的制备方法 | |
| CN102018254A (zh) | 一种以竹汁、桑椹汁为原料生产饮料的方法 | |
| CN103689743B (zh) | 一种高丽红参桑椹饮料的制备方法 | |
| CN107668683A (zh) | 一种余甘子酵素的生产工艺 | |
| CN107668702A (zh) | 一种枳椇酵素的生产工艺 | |
| CN103749827B (zh) | 一种高丽红参无花果茶的制备方法 | |
| CN103725467B (zh) | 一种高丽参红葡萄酒的制备方法 | |
| CN102366134B (zh) | 弥猴桃血耳汁饮料及其制备方法 | |
| CN108029921A (zh) | 一种沙果发酵饮料及其制备方法 | |
| CN104286280A (zh) | 一种木瓜红茶菌饮品 | |
| CN104397792A (zh) | 一种杏鲍菇姜汁饮料的制作方法 | |
| CN106561826A (zh) | 一种红枣枸杞功能型调配乳的制备方法 | |
| CN103689742B (zh) | 一种高丽红参无花果饮料的制备方法 | |
| CN108315115A (zh) | 一种桃花啤酒及其制备方法 | |
| CN103750425B (zh) | 一种高丽红参罗汉果汤的制备方法 | |
| CN103719499B (zh) | 一种高丽红参茶的制备方法 | |
| CN103689744B (zh) | 一种高丽红参龙眼饮料的制备工艺 | |
| CN103340252A (zh) | 四季茶强身保健饮料 | |
| CN103689602B (zh) | 一种高丽红参口服液的制备方法 | |
| CN107969586A (zh) | 一种荷花发酵饮料及制作方法 | |
| CN105341911A (zh) | 一种杏鲍菇土茯苓发酵饮料的加工方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| PP01 | Preservation of patent right |
Effective date of registration: 20190905 Granted publication date: 20141203 |
|
| PP01 | Preservation of patent right | ||
| PD01 | Discharge of preservation of patent | ||
| PD01 | Discharge of preservation of patent |
Date of cancellation: 20210905 Granted publication date: 20141203 |
|
| CP03 | Change of name, title or address | ||
| CP03 | Change of name, title or address |
Address after: 264200 No. 58, Taibei Road, Lingang Economic and Technological Development Zone, Weihai City, Shandong Province Patentee after: Shenyuanzhuang Biotechnology Co.,Ltd. Address before: No.58, Taibei Road, Lingang Economic and Technological Development Zone, Weihai City, Shandong Province Patentee before: WEIHAI HUANCUILOU RED GINSENG TECHNOLOGY Co.,Ltd. |
|
| PP01 | Preservation of patent right | ||
| PP01 | Preservation of patent right |
Effective date of registration: 20240805 Granted publication date: 20141203 |